Zoekresultaten - 13 results
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
this short summary presents the pathological basis and considers various questions related to screening for cervical cancer. As also reported in earlier reviews, the meta-analysis by Kleijnen Systematic ...
Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer.
intraepithelial neoplasia or worse (CIN2 +) or grade 3 cervical intraepithelial neoplasia or worse (CIN3 +) in women with ASC-H. An additional question that was assessed was whether triage would be useful in light ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
tests, validated assays which assure high-quality screening need to be identified. A systematic review was conducted to answer the question which hrHPV tests fulfil the criteria defined by an international ...
Metaprop: a Stata command to perform meta-analysis of binomial data.
have become an essential tool in synthesizing evidence on clinical and epidemiological questions derived from a multitude of similar studies assessing the particular issue. Appropriate and accessible ...
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
https://www.sciensano.be/nl/biblio/eurogin-2011-roadmap-prevention-and-treatment-hpv-related-disease
intervals are priorities for pooled analyses and further research, whereas feasibility questions can be addressed through screening programs. HPV vaccination will reduce the burden of cervical precancer and ...
Cervical cytology biobanks as a resource for molecular epidemiology.
can contribute in answering questions on the natural history of HPV infection and HPV-induced lesions and cancers, screening effectiveness, exploration of new biomarkers, and surveillance of short- and ...
Symptoms and clinical signs associated with hospital admission and mortality for heart failure.
physicians completed a follow-up form with questions about the final diagnosis, evolution and outcome. In total 557 patients with confirmed heart failure were recorded (median age = 78 years). Hospitalisation ...
How to evaluate emerging technologies in cervical cancer screening?
questions. We observe that good guidelines on assessment of evidence for screening questions are currently lacking. Guidelines for diagnostic research (STARD), involving systematic application of the reference ...
Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
genotyping of cervical cell samples and linkage with vaccine registries, are an important resource to address pending questions of the effect of HPV vaccination. Research is warranted to disentangle the causal ...
Cervical cytology biobanking in Europe.
biological research. In particular, it can contribute to answering questions on the natural history of HPV infection and HPV-induced lesions and cancers, screening effectiveness, exploration of new biomarkers, ...